An amphenone derivative, 2-methyl-1,2-bis-(3-pyridyl) -propanone (SU-4885), has become available which, when administered in the proper dosage to human subjects and experimental animals, selectively inhibits 11/8-hydroxylation (8, 9) .
Under these circumstances, 11-desoxyhydrocortisone (Compound S) is produced in normal individuals in place of cortisol. In an attempt to shed additional light on the underlying pathogenesis of this disease, SU-4885 was administered to patients with congenital adrenal hyperplasia.
METHODS AND MATERIALS
After adequate control periods of daily urine collections, 750 mg of SU-4885 was administered orally every 4 hours for 6 doses, and urine collections were continued for at least one day after the cessation of the drug administration. Three normal individuals (A.F., M.N. and D.M.) were used as controls, whereas three patients with documented congenital adrenal hyperplasia, not receiving steroid therapy (E.B., D.P. and M.G.), were given SU-4885 under identical circumstances.
For the study of C-21 urinary metabolites, aliquots of the 24-hour urine specimens were hydrolyzed with p-glucuronidase,' 750 U per ml for 48 hours at pH 5.0, and extracted twice with equal volumes of ethyl acetate. After being washed with small volumes of 1 N NaOH and distilled water, the extracts were dried, and portions representing 1 to 4 per cent of the day's output were applied to 1 inch wide strips of methanol-washed Whatman no. 3MM chromatography paper. Adjacent to each 1 inch strip a 0.5 inch marker strip was run, to which had been applied the same extract in one-half the amount. A parallel 1 inch strip carrying 25 ,ug amounts of the appropriate standards was employed in each chromatographic run. After being placed in a Bush B5 tank (10), the strips were equilibrated for 3 hours, and the solvent was then allowed to run a distance of 40 cm during about 2.5 hours. Equilibration and running were both done at room temperature.
After the paper had been dried in room air for a few minutes, steroids were located on the standard and marker strips by treatment with blue tetrazolium (BT) reagent. (13) in comparison with known standards of THE and THS, both of which were run through the final color reaction.
Experience with this method has shown consistent recovery figures averaging 90 per cent, when one chromatographic step was used, and 80 per cent, when there were two chromatographic steps; these corrections were therefore applied to the final figures. Excellent approximation of the pure Silber-Porter spectrophotometric curve was noted in every case after subtraction of the sulfuric acid blank, and in most cases before sub-2THF, 3a,li,8,17a,21-tetrahydroxy-pregnan-20-one; allo -THF, 3a, 118,17a,21 -tetrohydroxy-allopregnan-20-one; THE, 3a,17a,21-trihydroxy-pregnane-11,20-dione; THS. 3a,17a,21-trihydroxy-pregnan-20-one. traction as well, so that the use of this blank made little difference to the final Allen-corrected value.
Identification of the measured group of cortisol metabolites was not carried out beyond establishing the identity of Rf values with those of standards, plus appropriate reactions to UV light, BT, and Silber-Porter reagents; the last of these, as used here with individual blanks and readings at three wave lengths, constitute a reasonably good test of specificity for the presence of a 21-hydroxyl group in a dihydroxyacetone configuration. Criteria for the identification of THS, in addition to those mentioned above, included in all cases the identity of Rf in a second chromatographic system, plus in most cases the preparation and chromatography of a bismuthate oxidation derivative which was Zimmermann positive and had a mobility identical with that of etiocholanolone. In addition, from one 24-hour urine after SU-4885 administration, following multiple paper chromatography, several milligrams of a substance were crystallized which had an infrared spectrum identical with that of authentic THS, and a melting point of 184 to 1860 C, which agrees closely with that of 184 to 185°C reported for THS by Eberlein and Bongiovanni (14) .
It should be noted that values for the THF, allo-THF, THE group are expressed in terms of a THE standard, and those for THS in terms of a THS standard. Employing the Silber-Porter reaction as described, it was found that THS has a chromogenicity which is 80 per cent that of THE.
The 17-ketosteroids and total ketogenic steroids were determined by the method of Norymberski, Stubbs and West (15) . Pregnanetriol 3 was analyzed by the Bongiovanni and Eberlein technique (16), evidence for the specificity of which has been discussed by the authors.
RESULTS
Normal subjects. The administration of SU-4885 to normal subjects resulted in a marked increase in the urinary ketogenic steroids, reaching maximal levels in the 24 hours following the administration of the drug. Consequently, urines collected during this period were chosen for steroidal analysis (Table I) .
Chromatographic analysis of the cortisol metabolites revealed control values similar to those reported by others (17, 18) . The control values of THS, however, are somewhat higher than have been noted previously (19) . After SU-4885 administration the cortisol metabolites were considerably reduced, and THS increased to levels as high as 20 mg per day. Jenkins and co-workers (20) have noted a similar rise in urinary THS when SU-4885 was given to normal subjects.
A modest increase in urinary pregnanetriol values was also noted after SU-4885 treatment (Table I ).
The urinary excretion of 17-ketosteroids rose variably following the administration of SU-4885 (Table II) .
Patients with congenital adrenal hyperplasia. During the control period, decreased to normal amounts of THE, THF and allo-THF could be detected in the urine of all three patients with congenital adrenal hyperplasia. On the other hand, the pregnanetriol values were consistently elevated (Table I) , accounting in large part for the elevated ketogenic steroids manifested by these patients during the control period.
Administration of SU-4885 to these three patients resulted in a considerably greater increase in the total urinary ketogenic steroids than was found in normal subjects. Although an increase in THS occurred in this group, it was of much smaller magnitude than that observed in the normal group and constituted only a relatively minute share of the total ketogenic steroids. The bulk of the ketogenic steroids was found in the pregnanetriol fraction. Diminished excretion of the metabolites of cortisol was also noted, similar to that seen in the normal controls. The urinary 17-ketosteroids rose in all patients following SU-4885 administration (Table II) . DISCUSSION Liddle and associates (8) and Jenkins and associates (9) 2. Individual urinary C-21 steroidal metabolites were separated chromatographically and quantitated, before and after SU-4885 administration. Cortisol metabolites decreased in the normal subjects in response to SU-4885 and were replaced by large amounts of tetrahydro S, a metabolite of 11-desoxyhydrocortisone. In the adrenal hyperplasia group, initially low levels of cortisol metabolites declined still further after SU-4885; tetrahydro S appeared, but in much smaller amounts than in the normal subjects. Pregnanetriol, however, rose strikingly after SU-4885 from initially elevated values in the hyperplasia group.
3. In addition to demonstrating a considerable pituitary-adrenal reserve, these data are interpreted as providing further evidence of a relative defect of 21 hydroxylation in congenital adrenal hyperplasia.
